About Rizlab Health
Rizlab specializes in rapid blood testing diagnostics. The company is working to get complete blood count measurements diagnostics allowing for results within minutes using a wireless artificial intelligence-fired pocket-sized fully electronic analyzer.
Missing: Rizlab Health's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Rizlab Health's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Rizlab Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Rizlab Health is included in 5 Expert Collections, including Digital Health.
Startups recreating how healthcare is delivered
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Latest Rizlab Health News
Oct 1, 2021
Most big accelerators tend to dedicate some of their resources to dauntingly hard science problems and the companies taking them on… but for SOSV’s IndieBio , it’s the primary focus. Last time we checked in with IndieBio , their companies were working on everything from lozenges to treat gum disease, to vertical farms for the sustainable production of shrimp, to saving the bees. While IndieBio’s next Demo Day is still a few months out, the companies in their next New York batch have been selected and are already chipping away at a whole new set of problems — things like battling opioid addiction, improving crop yields amidst climate change, or making better/safer leather alternatives from stuff we’d otherwise throw away. I hopped on a call with IndieBio NY’s Chief Science Officer Julie Wolf, who told me a bit about what each company in this latest New York batch is working on. Here’s my understanding of each company in the new class, in alphabetical order: Ceragen : Making a microbe-based “inoculant” that improves crop production in hydroponic greenhouses, using beneficial bacteria to help plants increase heat resistance, battle root rot and more. The team says they’ve seen yield increases of up to 20% in tomatoes (think more fruit, not bigger fruit.) HelEx : Building what they call an “an intelligent GPS for gene-editing” to enable faster, safer development of CRISPR-based gene therapies. Inso Bio : Built by a team out of Cornell, Inso is working on dramatically simplifying the process of genomic sequencing and sample processing — taking what Wolf calls a “multi-step, high touch” process that “requires a lot of lab personnel” (and is thus often backlogged for months within any given lab) and turning it into a piece of hardware that handles it all. Image Credits: Kinoko Kinoko Labs : Whole-cut meat alternatives (think steaks and cutlets instead of nuggets and burger patties) grown/made from fungus, using fungal mycelium to create a meat alternative with taste/textures more like that of actual meats. The company currently has both chicken and steak prototypes in development. Kutanios: Working on a peptide-based product that, when applied topically, would help prevent damage/aging caused by the sun — all while being biodegradable and safe for the environment. One of the founders is Dr. Norman Miller, a scientist best known for co-authoring a 1975 hypothesis on HDL’s role in protecting against heart disease — in other words, for discovering that there’s such a thing as “good” cholesterol. Kyomei : Wolf tells me that this team is working on growing meat proteins (myoglobin) within plants at scale, which could be extracted and added to plant-based meat-alternatives to “give them that umami taste.” Pannex Therapeutics : Looking to combat the ever-worsening opioid epidemic, Pannex is working on what it expects to be a non-addictive painkiller. The company’s website says its drug (PNX3) “docks to Pannexin 1 channel and blocks it” — regulating one of the ways the brain processes ATP as pain. RizLab Health : Antibiotic-resistant “superbug” bacterial infections are terrifying, and the overuse of unnecessary antibiotics only makes the situation worse. A spin-off out of Rutgers, RizLab is working on an in-office/portable machine for rapid CBC tests that can help a doctor quickly determine if an infection is viral or bacterial — thus, hopefully, halting the tendency to throw antibiotics at everything. Image Credits: TomTex TômTex : Leather alternatives made from seafood waste — they’re turning things like crab or shrimp shells into chitosan, a biodegradable polymer which they’re then able to turn into cheaper yet more sustainable alternatives to leather. The team has already won a number of awards from groups including LVHM (the holding co. behind companies like Louis Vuitton, Fendi, Christian Dior, etc.) Upright : Working on “oatmilk as nutritious as dairy,” using concentrated oat protein (rather than more commonly used things like pea protein or soy protein) to keep it hypo-allergenic.
Rizlab Health Frequently Asked Questions (FAQ)
When was Rizlab Health founded?
Rizlab Health was founded in 2018.
Where is Rizlab Health's headquarters?
Rizlab Health's headquarters is located at 303A College Road East, Princeton.
What is Rizlab Health's latest funding round?
Rizlab Health's latest funding round is Seed - II.
How much did Rizlab Health raise?
Rizlab Health raised a total of $200K.
Who are the investors of Rizlab Health?
Investors of Rizlab Health include SOSV and IndieBio.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.